Frontlight ResearchEarly access
Peripheral artery disease trials in Latvia
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in LatviaReducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Where
- Riga
- Age
- 18 years and over
- People
- 7,050 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00 - No phaseTaking peopleSelective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)
- Where
- Riga
- Age
- 50 years and over
- People
- 600
- Run by
- Pauls Stradins Clinical University Hospital
See details and how to joinNCT06250790